RNA Synthesis Initiates In Vitro Conversion of M13 DNA to Its Replicative Form

AUTOR(ES)

Wickner, William

RESUMO

Soluble enzyme fractions from uninfected Escherichia coli convert M13 and ϕX174 viral single strands to their double-stranded replicative forms. Rifampicin, an inhibitor of RNA polymerase, blocks conversion of M13 single strands to the replicative forms in vivo and in vitro. However, rifampicin does not block synthesis of the replicative forms of ϕX174 either in vivo or in soluble extracts. The replicative form of M13 synthesized in vitro consists of a full-length, linear, complementary strand annealed to a viral strand. The conversion of single strands of M13 to the replicative form proceeds in two separate stages. The first stage requires enzymes, ribonucleoside triphosphates, and single-stranded DNA; the reaction is inhibited by rifampicin. The macromolecular product separated at this stage supports DNA synthesis with deoxyribonucleoside triphosphates and a fresh addition of enzymes; ribonucleoside triphosphates are not required in this second stage nor does rifampicin inhibit the reaction. We presume that in the first stage there is synthesis of a short RNA chain, which then primes the synthesis of a replicative form by a DNA polymerase.

Documentos Relacionados

• Filamentous coliphage M13 as a cloning vehicle: insertion of a HindII fragment of the lac regulatory region in M13 replicative form in vitro.
• Thymine glycols and urea residues in M13 DNA constitute replicative blocks in vitro.
• Studies on the structure of replicative intermediates in bacteriophage M13 single stranded DNA synthesis.
• Synthesis of phage M13 coat protein and its assembly into membranes in vitro.
• A Possible Role for RNA Polymerase in the Initiation of M13 DNA Synthesis